GEVOBasic Materials · Specialty ChemicalsGEVO Stock Forecast: Gevo, Inc. Price Predictions for 2026-2027
The 4 Wall Street analysts covering Gevo, Inc. hold a median 12-month price target of $2.88 — +96.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 65 of 100 as at 1 Aug 2026 — in the upper half.
GEVO stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Gevo, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (93): Sales and profits are climbing, and climbing faster than before.
Value (29): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own Gevo, Inc. — and when they’d sell — is the membership.
GEVO stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on GEVO, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +96.9% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 22 May 2026 | UBS | Maintains | Neutral | $2.25 → $2.00 |
| 16 Apr 2026 | Northland Capital Markets | Maintains | Outperform | — |
| 31 Dec 2025 | Northland Capital Markets | Reiterates | Outperform | — |
| 17 Sept 2025 | UBS | Maintains | Neutral | — |
| 30 May 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 2 Apr 2025 | UBS | Maintains | Neutral | — |
| 28 Mar 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 10 Mar 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 4 Feb 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 13 Nov 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 22 Oct 2024 | UBS | Maintains | Neutral | — |
| 18 Oct 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 13 Sept 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 12 Aug 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 3 May 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 10 Apr 2024 | UBS | Maintains | Neutral | — |
| 8 Mar 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 13 Dec 2023 | UBS | Maintains | Neutral | — |
| 27 Nov 2023 | Stifel | Maintains | Buy | — |
| 22 Aug 2023 | Stifel | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
GEVO analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Gevo, Inc. (GEVO) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −10.5×
- Price / sales
- 2.1×
- Price / book
- 0.8×
- EV / EBITDA
- 24.3×
Cheaper than 93% of US stocks
Cheaper than 52% of US stocks
Cheaper than 78% of US stocks
Cheaper than 12% of US stocks
- Revenue growth (YoY)
- 47.5%
- Earnings growth (YoY)
- 47.5%
- Gross margin
- 52.9%
- Operating margin
- −11.4%
- Net margin
- −19.4%
Higher than 86% of US stocks
Higher than 76% of US stocks
Higher than 68% of US stocks
Higher than 25% of US stocks
Higher than 16% of US stocks
- Return on equity
- −6.9%
- Return on assets
- −0.8%
- Dividend yield
- —
Higher than 38% of US stocks
Higher than 41% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
GEVO vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. GEVO appears on the weeks it earns a place.
Frequently asked questions about GEVO stock
What is the GEVO stock price forecast for 2026-2027?
The 4 Wall Street analysts covering Gevo, Inc. have a median 12-month price target of $2.88, with estimates ranging from $1.8 to $14. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is GEVO stock a buy right now?
Of the 4 analysts covering Gevo, Inc., 2 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Gevo, Inc. 65 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank GEVO?
As at 1 Aug 2026, Gevo, Inc. ranks 65 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (93 of 100).
Will GEVO stock go up?
No one can know that. What the data says: the median 12-month target from 4 analysts implies +96.9% from the last close, and Ticker Nerd's factor model ranks Gevo, Inc. 65 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the GEVO stock forecast for 2030?
No analyst covering Gevo, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for GEVO are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1.8 to $14 over the next 12 months.
How has GEVO stock performed over the past year?
Gevo, Inc. returned +19.7% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Gevo, Inc. do?
Gevo Inc. is a renewable chemicals and next-generation biofuels company that develops, manufactures, and markets sustainable, low-carbon fuels and chemical products.
About Gevo, Inc.
Gevo Inc. is a renewable chemicals and next-generation biofuels company that develops, manufactures, and markets sustainable, low-carbon fuels and chemical products. It focuses on commercializing advanced renewable alternatives to petroleum-based products, including sustainable aviation fuel, renewable premium gasoline, renewable natural gas, diesel fuel, and chemicals for plastics and materials. Gevo operates through segments such as Gevo, GevoFuels, and GevoRNG, involving research and development of proprietary biocatalysts and isobutanol technology, production of drop-in fuels compatible with existing infrastructure, and operation of facilities that capture methane from dairy manure to produce pipeline-quality renewable natural gas. The company leverages low-carbon renewable carbohydrates, electricity, and natural gas as inputs to create energy-dense hydrocarbons that perform as well as or better than fossil-based equivalents, while supporting carbon abatement and rural economies through regenerative agriculture and circular economy principles. Founded in 2005 and headquartered in Englewood, Colorado, Gevo plays a key role in the transition to low-carbon transportation fuels and sustainable chemicals.
CEO Dr. Paul D. Bloom · 151 employees · United States · https://gevo.com